GAD-7 Anxiety Screener
Take the validated GAD-7 anxiety screener (Spitzer 2006). Seven items, two-week window, scored 0–21 with severity bands. Public domain instrument.
What the GAD-7 measures
The Generalized Anxiety Disorder 7-item scale (GAD-7) was developed by Spitzer and colleagues in 2006 and published in Archives of Internal Medicine. It asks how often, over the last two weeks, you’ve been bothered by seven symptoms commonly seen in generalized anxiety disorder — from feeling nervous or on edge to becoming easily annoyed and feeling afraid as if something awful might happen.
Each item is scored 0–3 (not at all → nearly every day) for a total of 0–21.
Severity bands
| Score | Severity | Suggested next step |
|---|---|---|
| 0–4 | Minimal anxiety | Self-monitor; reassess if symptoms persist |
| 5–9 | Mild anxiety | Watchful waiting; consider repeating in 2–4 weeks |
| 10–14 | Moderate anxiety | Consider clinical conversation |
| 15–21 | Severe anxiety | Active treatment strongly recommended |
A cutoff score of 10 or higher is widely used to flag possible GAD warranting further evaluation. The instrument also performs reasonably well as a generic screener for panic disorder, social anxiety disorder, and post-traumatic stress disorder, although specialized instruments (PHQ-PD, SPIN, PCL-5) are preferred for those.
Why this is a public-domain tool
The GAD-7 was developed with funding from Pfizer, which formally waived copyright. Anyone may use, reproduce, translate, display, or distribute the instrument without permission. The same applies to PHQ-9, PHQ-2 and PHQ-15. This means the screener you take here is the identical instrument used in NHS, ACOG, AAFP and primary-care settings worldwide.
Limitations
- The two-week window misses chronic patterns that don’t show up in short bursts.
- Cultural and linguistic factors affect symptom expression — validated translations exist for many languages, but translation quality varies.
- A high score does not equal a diagnosis — only a clinical assessment can do that.
- A low score does not rule out anxiety; if your daily functioning is impaired, please talk to a clinician regardless of what the screener says.
Privacy
All calculation happens in your browser. We never see, log, or store your answers. Anonymous, aggregate events (the severity bucket reached) are sent to a privacy-first analytics service.
Frequently asked questions
Is this a clinical diagnosis?
Why a two-week window?
What do the scores mean?
What does a GAD-7 score of 10 mean?
What does a GAD-7 score of 15 mean?
At what GAD-7 score should I worry?
GAD-7 score 12 — should I see a doctor?
GAD-7 vs PHQ-9 — what's the difference?
GAD-7 vs SPIN — when do I use which?
Is the GAD-7 valid for teenagers?
How often should I retake GAD-7?
Can I have an anxiety disorder with a low GAD-7 score?
Test anxiety vs anxiety disorder — when does it cross the line?
Does my data leave my device?
Sources
- A brief measure for assessing generalized anxiety disorder: the GAD-7 — Archives of Internal Medicine (Spitzer et al., 2006) (peer reviewed, retrieved 2026-04-27)
- Generalised anxiety disorder and panic disorder in adults — NICE CG113 — National Institute for Health and Care Excellence (NICE) (guideline, retrieved 2026-04-27)
- PHQ and GAD-7 instructions and scoring — Pfizer (public domain — copyright waived) (guideline, retrieved 2026-04-27)